Pay in 4 interest-free payments of $6.12 Learn more
Ships within 48 hours · Estimated delivery Aug 18 - Aug 23
TB-500 10mg A synthetic fragment of Thymosin Beta-4 studied for its interaction with G-actin sequestration, angiogenesis pathway activity, and cell migration mechanisms in preclinical research
Why experts are watching: Wearables pushed recovery into the mainstream by tracking HRV, sleep stages, and readiness scores
Rather than printing and filing paper forms, digital form solutions allow patients to complete and sign consent on tablet or kiosk, with automated storage linked directly to the patients clinical record
Kidney protection1.0mg/wk The FLOW dose
The Phase 2 obesity trial published in the New England Journal of Medicine reported substantial weight reduction over 48 weeks, while a separate Phase 2 trial in people with type 2 diabetes evaluated glycemic and body-weight effects
No form of GHK-Cu, BPC-157, or TB-500 is FDA-approved for human use
